Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: A RECORD-1 subgroup analysis

S. Bracarda, T. E. Hutson, C. Porta, R. A. Figlin, E. Calvo, V. Grünwald, A. Ravaud, R. Motzer, D. Kim, O. Anak, A. Panneerselvam, B. Escudier

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: A RECORD-1 subgroup analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences